| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 10% | $54,973,720 | 25,931,000 | Vivo Opportunity Fund Holdings, L.P. | 29 Sep 2025 | |||
| Woodline Partners LP | 9.9% | $14,293,092 | 7,125,881 | Woodline Partners LP | 30 Sep 2025 | |||
| BIOTECHNOLOGY VALUE FUND L P | 10% | $10,365,208 | 5,167,618 | BVF PARTNERS L P/IL | 30 Sep 2025 | |||
| Commodore Capital LP | 9.9% | $9,588,711 | 4,522,977 | Commodore Capital LP | 26 Sep 2025 | |||
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | $9,331,180 | 4,401,500 | RA Capital Management, L.P. | 26 Sep 2025 | |||
| PERCEPTIVE ADVISORS LLC | 7.3% | $13,088,916 | 3,471,861 | Perceptive Advisors LLC | 14 Jan 2026 | |||
| RTW INVESTMENTS, LP | 10% | $1,311,149 | 1,024,335 | RTW Investments, LP | 31 Dec 2024 |
As of 30 Sep 2025, 34 institutional investors reported holding 28,023,938 shares of SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (SABS). This represents 59% of the company’s total 47,559,740 outstanding shares.
The largest institutional shareholders of SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (SABS) together control 59% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 24% | 11,420,000 | 1.8% | $22,954,200 | |
| RA CAPITAL MANAGEMENT, L.P. | 9.3% | 4,401,500 | 0.11% | $8,847,015 | |
| Commodore Capital LP | 9.3% | 4,401,500 | 0.43% | $8,847,015 | |
| Woodline Partners LP | 6% | 2,850,881 | 0.03% | $5,730,271 | |
| Sessa Capital IM, L.P. | 4.6% | 2,198,457 | +380% | 0.11% | $4,418,899 |
| BVF INC/IL | 2% | 932,697 | +1.6% | 0.08% | $1,874,721 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.2% | 566,395 | 0.27% | $1,138,454 | |
| VANGUARD GROUP INC | 0.77% | 365,753 | +30% | 0% | $735,163 |
| HB Wealth Management, LLC | 0.65% | 307,500 | 0% | $618,075 | |
| AWM Investment Company, Inc. | 0.42% | 200,000 | 0.04% | $402,000 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.18% | 85,718 | +1.1% | 0% | $172,317 |
| RENAISSANCE TECHNOLOGIES LLC | 0.17% | 80,840 | +633% | 0% | $162,488 |
| Pathstone Holdings, LLC | 0.11% | 50,650 | 0% | 0% | $101,807 |
| Virtu Financial LLC | 0.04% | 19,982 | 0% | $40,000 | |
| Kovitz Investment Group Partners, LLC | 0.04% | 19,201 | 0% | 0% | $38,594 |
| First PREMIER Bank | 0.04% | 18,986 | 0% | 0.01% | $38,000 |
| DIMENSIONAL FUND ADVISORS LP | 0.03% | 15,781 | 0% | $31,720 | |
| ADAR1 Capital Management, LLC | 0.03% | 15,000 | 0% | $30,150 | |
| UBS Group AG | 0.03% | 13,221 | +24% | 0% | $26,574 |
| Kestra Advisory Services, LLC | 0.03% | 11,930 | 0% | 0% | $23,979 |
| NORTHERN TRUST CORP | 0.02% | 11,387 | 0% | 0% | $22,888 |
| GOLDMAN SACHS GROUP INC | 0.02% | 11,221 | 0% | $22,554 | |
| CAXTON CORP | 0.02% | 10,935 | 0.1% | $21,979 | |
| BlackRock, Inc. | 0.01% | 6,339 | -9.5% | 0% | $12,741 |
| OSAIC HOLDINGS, INC. | 0.01% | 4,824 | -2.3% | 0% | $9,994 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 28,023,938 | $56,328,113 | +$52,469,483 | $2.01 | 34 |
| 2025 Q2 | 1,923,874 | $3,369,565 | -$378,633 | $1.76 | 25 |
| 2025 Q1 | 2,209,552 | $2,994,479 | -$1,776,863 | $1.36 | 26 |
| 2024 Q4 | 2,628,252 | $10,098,558 | -$1,284,579 | $3.80 | 25 |
| 2024 Q3 | 3,141,736 | $8,482,377 | +$68,507 | $2.70 | 24 |
| 2024 Q2 | 3,127,151 | $9,694,108 | -$923,500 | $3.10 | 21 |
| 2024 Q1 | 3,339,666 | $15,162,138 | -$15,608,797 | $4.54 | 23 |
| 2023 Q4 | 8,791,109 | $6,055,351 | +$6,055,351 | $0.69 | 3 |